"Survivor's Plea: Increase Funding and Resources for Rare Sarcoma Cancer"

Stephanie Webster, diagnosed with osteosarcoma, a rare form of cancer, was given a prognosis of less than five months to live. However, she refused to give up and self-funded a targeted immunotherapy treatment usually used for melanoma or lung cancer. The treatment proved successful, and today her scans are clear. Advocates and survivors of sarcoma are calling for increased funding for clinical trials to improve treatment options for this challenging and deadly disease.